Discuss This Drug

esketamine

CHEBI:CHEBI_60799

Definition

The S- (more active) enantiomer of ketamine.

Chemical Information

Molecular Formula
C13H16ClNO
Molecular Mass
237.72500
Charge
0
SMILES
CN[C@@]1(CCCCC1=O)c1ccccc1Cl
InChI
InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1
InChIKey
YQEZLKZALYSWHR-ZDUSSCGKSA-N

Alternative Names

  • (-)-ketamine
  • (2S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone
  • (S)-(-)-ketamine
  • (S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone
  • (S)-ketamine
  • esketamine

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
2119365
oboInOwl#hasDbXref
Reaxys:4295313
core#notation
CHEBI:60799

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
2119365
oboInOwl#hasDbXref
Reaxys:4295313
oboInOwl#id
CHEBI:60799
core#notation
CHEBI:60799
rxcui
2119391
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
SOLUTION
dea_schedule
CIII
marketing_start_date
20010711
package_marketing_start_date
11-JUL-01
route
NASAL
active_ingredient_strength
28 mg/.2mL
labeler_name
Janssen Pharmaceuticals Inc.
generic_name
ESKETAMINE HYDROCHLORIDE
product_ndc
10920-700
spl_id
20a1ad6b-3e90-b05b-e063-6294a90a6a22
active_ingredient_name
ESKETAMINE HYDROCHLORIDE
package_ndc
10920-700-01
package_description
1 BAG in 1 DRUM (10920-700-01) / 10 kg in 1 BAG
brand_name
Spravato
brand_name_base
Spravato
application_number
NDA211243
manufacturer_name
Janssen Pharmaceuticals Inc.
unii
L8P1H35P2Z
spl_set_id
d81a6a79-a74a-44b7-822c-0dfa3036eaed
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#is_enantiomer_of
http://purl.obolibrary.org/obo/CHEBI_580604
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_1470
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect29122
owl#someValuesFrom
t3449759
owl#annotatedSource
t256068